High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease.
CONCLUSIONS: In patients with PAD, HPR did not have a significant impact on outcomes within the first year after percutaneous endovascular intervention.
PMID: 27058802 [PubMed - as supplied by publisher]
Source: VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases - Category: Surgery Authors: Bernlochner I, Jaitner J, Fries V, Dommasch M, Mayer K, Ott I, Langwieser N, Fusaro M, Laugwitz KL, Kastrati A, Ibrahim T Tags: Vasa Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Clopidogrel | Heart | Peripheral Vascular Disease (PVD) | Plavix | Study | Surgery